Keryx announces positive results for Zernez, an iron-based phosphate binder |
![]() |
Bloomberg: The trial of 146 people tested three doses of Zerenex for 28 days and found the two higher doses -- six and eight pills a day -- lowered phosphate levels by 25 percent and 29 percent, respectively, the New York-based company said today in a statement |